ArticleCureus2026
Microscopic Polyangiitis Following Kawasaki Disease in a Patient With Autoimmune Predisposition.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is rare in children, and its pathogenesis remains incompletely understood. Current evidence suggests that complex interactions between genetic susceptibility and environmental triggers contribute to disease development. We report a case of pediatric-onset microscopic polyangiitis (MPA) preceded by recurrent cutaneous manifestations and occurring in a patient with a history of Kawasaki disease and a strong family history of autoimmune diseases. A 14-year-old boy presented with recurrent painful edematous erythema involving the palms, wrists, and dorsum of the feet. Several months later, he developed fever, arthralgia, oral aphthous ulcers, and weight loss. Urinalysis revealed hematuria and proteinuria, and serum myeloperoxidase (MPO)-ANCA levels were markedly elevated. Renal biopsy demonstrated pauci-immune crescentic glomerulonephritis, leading to the diagnosis of MPA. Remission induction therapy with corticosteroids and cyclophosphamide achieved sustained clinical remission without renal dysfunction. The patient had a history of Kawasaki disease in infancy, more than a decade before the onset of MPA. In addition, his mother had rheumatoid arthritis and myasthenia gravis, and his younger sister had immune thrombocytopenic purpura. This case raises the possibility that prior immune-mediated vascular inflammation, together with autoimmune genetic predisposition, may contribute to the later development of MPO-ANCA-associated vasculitis. Further accumulation of similar cases may help clarify the immunopathogenic relationship between Kawasaki disease and AAV.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.